Growth Metrics

Boston Scientific (BSX) Income from Continuing Operations (2016 - 2026)

Boston Scientific's Income from Continuing Operations history spans 18 years, with the latest figure at 1338000000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 99.11% to 1338000000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 3559000000.0, a 75.75% increase, with the full-year FY2025 number at 2892000000.0, up 56.66% from a year prior.
  • Income from Continuing Operations hit 1338000000.0 in Q1 2026 for Boston Scientific, up from 670000000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for BSX hit a ceiling of 1338000000.0 in Q1 2026 and a floor of 111000000.0 in Q1 2022.
  • Historically, Income from Continuing Operations has averaged 492294117.65 across 5 years, with a median of 493000000.0 in 2024.
  • Biggest five-year swings in Income from Continuing Operations: crashed 67.45% in 2022 and later skyrocketed 257.45% in 2023.
  • Tracing BSX's Income from Continuing Operations over 5 years: stood at 141000000.0 in 2022, then skyrocketed by 257.45% to 504000000.0 in 2023, then rose by 11.51% to 562000000.0 in 2024, then increased by 19.22% to 670000000.0 in 2025, then soared by 99.7% to 1338000000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for BSX at 1338000000.0 in Q1 2026, 670000000.0 in Q4 2025, and 756000000.0 in Q3 2025.